Search Login Register

Adenosine-5'-(N-ethylcarboxamide) (NECA) Summary

Description: A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity.

Also Known As: NECA; Adenosine-5'-N-ethyluronamide; N6-Ethyl-carboxamido Adenosine; 5' N Ethylcarboxamidoadenosine; Adenosine 5' N ethyluronamide Show All >>

Networked: 170 relevant articles (7 outcomes, 8 trials/studies) for this Bio-Agent

Key Diseases for which Adenosine-5'-(N-ethylcarboxamide) is Relevant

  1. Seizures (Seizure) : 4 outcomes 1 study in 13 results
  2. Catalepsy : 1 outcome 1 study in 7 results
  3. Memory Disorders (Memory Loss) : 1 outcome in 1 result
  4. Hemorrhage : 1 outcome in 1 result
  5. Contracture : 1 outcome in 1 result
Show All >>

Drugs Related to Adenosine-5'-(N-ethylcarboxamide)

  1. Adenosine-5'-(N-ethylcarboxamide) (NECA)
  2. Adenosine
  3. Purinergic P1 Receptors (Adenosine Receptor)
  4. 2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosine
  5. Adenosine A2A Receptor (Adenosine A2A Receptors)
  6. Pentylenetetrazole (Metrazol)
  7. Adenosine A1 Receptor
  8. P-2 (P 2)
  9. Cyclic AMP (AMP, Cyclic)
  10. Adenosine Triphosphate (ATP)
Show All >>

Therapies Related to Adenosine-5'-(N-ethylcarboxamide)

  1. Injections
  2. Organ Transplantation
  3. Resuscitation
  4. Cardiopulmonary Bypass (Heart-Lung Bypass)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.